SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.

Autres langues Sihuan Pharmaceutical Holdings Group Ltd.

Actions

460 BMG8162K1137

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:20 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,56 ^HKD	+3,70 %		+9,80 %	-13,85 %

25/04	Une unité de Sihuan Pharma remporte un appel d'offres pour la fourniture de produits d'insuline au gouvernement chinois	MT
29/03	Sihuan Pharmaceutical réduit sa perte en 2023 grâce à l'absence de dépréciation d'actifs et d'investissements	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sihuan Pharma Unit Wins Bid to Supply Insulin Products to Chinese Government	25/04
Sihuan Pharmaceutical Narrows 2023 Loss on Absence of Asset, Investment Impairments	29/03
Sihuan Pharmaceutical Holdings Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Sihuan Pharmaceutical's RF Device Wins Registration Approval in China	25/03
Sihuan Pharmaceutical Holdings Unit Forms Consortium for Ji Yao Restructuring	08/02
China Approves Drug Registration for Sihuan Pharmaceutical Unit's Type 2 Diabetes Drug	23/01
Sihuan Pharmaceutical Holdings Group Ltd. Receives Registration Approval from National Medical Products Administration for Proline Janagliflozin Tablets	22/01
China Includes Four Injectables by Sihuan Pharma Associate in Drug Reimbursement List; Shares Rise 3%	10/01
China Grants Registration Approval to Sihuan Pharmaceutical's Insulin Products	08/01
Sihuan Pharmaceutical Holdings Group Ltd. Obtains Drug Registration Approval from the National Medical Products Administration of the People's Republic of China for the Treatment of Diabetes	08/01
China's Medical Products Administrator Approves Sihuan Pharma Unit's Diabetes Drug	25/10/23
National Medical Products Administration Approves IND Application of Insulin Degludec and Liraglutide Injection, Developed by Huisheng Biopharmaceutical	25/10/23
China Accepts New Drug Application of Sihuan Pharmaceutical Subsidiary's Breast Cancer Treatment	17/10/23
Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023	13/10/23
China Accepts New Drug Application for Sihuan Pharmaceutical Unit's Breast Cancer Tablets	05/09/23
Sihuan Pharmaceutical Swings to H1 Loss	29/08/23
Sihuan Pharmaceutical Holdings Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Sihuan Pharmaceutical's Revenue to Drop 30% in H1	03/08/23
Sihuan Pharmaceutical Holdings Group Ltd. Provides Unaudited Consolidated Guidance for the Six Months Ended 30 June 2023	02/08/23
China Approves Sihuan Unit's Clinical Trial for Diabetes Injections; Shares Fall 3%	06/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sihuan Pharmaceutical Holdings Group Ltd.

Actions

460

BMG8162K1137

Autres langues

Filtres